Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to improve the safety profile of a wide range of mRNA medicines.
The company utilises specialist in-house capabilities and strategic partnerships with leading researchers to build a growing pipeline of new proprietary drugs based on two technology platforms – Sofra™ (inflammation, autoimmunity, mRNA drug enhancement, and oncology) and Chroma™ (oncology).
Noxopharm’s management team has extensive and highly relevant experience spanning a wide range of activities, including over 100 years of combined pharma experience, 20+ drug launches in numerous therapeutic areas, involvement in more than 100 clinical trials, 60+ years of academic research and 150+ peer-reviewed publications.
A core strength at all levels of the company is a focus on external collaborations, whether with research institutions and academia, suppliers or industry partners both in Australia and overseas. These relationships enable Noxopharm and its network to efficiently develop new proprietary assets that have demonstrable commercial potential.
Likes and shares are not endorsements
Company Details
- Employees
- 15
- Founded
- -
- Address
- Suite 71, 159 Ridgecrop Drive, Sydney - Castle Hill,new South Wales 2154,australia
- in****@****arm.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- noxopharm.com
- Keywords
- psoriasis, lupus, chronic inflammation, oligonucleotides, mRNA vaccines, mRNA therapeutics, autoimmune disease, TLR7, TLR8, TBK1, preclinical research, oncology, drug development, biotechnology, nucleic acids, pharmaceutical, small molecule, RNA, RIG-I, inflammatory disease.
- HQ
- Sydney - Castle Hill, New South Wales
Noxopharm Limited Questions
Noxopharm Limited's website is noxopharm.com
Noxopharm Limited's LinkedIn profile is https://au.linkedin.com/company/noxopharm-limited
Noxopharm Limited has
15 employees.
View email and phone details for 15
employees at Noxopharm Limited.
Noxopharm Limited's industry is
Biotechnology Research
Noxopharm Limited's top competitors are
Ternarx,
Imugene Limited,
Myrio Tx,
Aucentra Therapeutics,
Immutep Limited,
Kazia Therapeutics Limited,
Carina Biotech,
Prescient Therapeutics,
Haemalogix Ltd,
Rhythm Biosciences Limited.
Noxopharm Limited's support email address is info@noxopharm.com
Noxopharm Limited's categories are Biotechnology Research
Noxopharm Limited's founding year is 2015
